Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126603832 | 12660383 | 2 | F | 20160728 | 20160914 | 20160817 | 20160920 | EXP | ZW-GILEAD-2016-0228706 | GILEAD | 52.00 | YR | A | M | Y | 0.00000 | 20160920 | OT | ZW | ZW |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126603832 | 12660383 | 1 | PS | EFAVIRENZ/EMTRICITABINE/TENOFOVIR DISOPROXIL FUMARATE | EFAVIRENZEMTRICITABINETENOFOVIR DISOPROXIL FUMARATE | 1 | Oral | 1 DF, QD | 511 | DF | 21937 | 1 | DF | TABLET | QD | ||||
| 126603832 | 12660383 | 2 | SS | BLEOMYCIN | BLEOMYCIN SULFATE | 1 | Intravenous (not otherwise specified) | 28.8 DF, Q3WK | 29 | DF | D | 0 | 28.8 | DF | Q3W | ||||
| 126603832 | 12660383 | 3 | SS | VINCRISTINE | VINCRISTINE | 1 | Intravenous (not otherwise specified) | 2 MG, Q3WK | 4 | MG | D | 0 | 2 | MG | Q3W | ||||
| 126603832 | 12660383 | 4 | SS | ETOPOSIDE. | ETOPOSIDE | 1 | Oral | 100 MG, Q3WK | 500 | MG | D | 0 | 100 | MG | Q3W | ||||
| 126603832 | 12660383 | 5 | SS | PACLITAXEL. | PACLITAXEL | 1 | Intravenous (not otherwise specified) | 183 MG, Q3WK | 915 | MG | U | 0 | 183 | MG | Q3W | ||||
| 126603832 | 12660383 | 6 | SS | PACLITAXEL. | PACLITAXEL | 1 | Intravenous (not otherwise specified) | UNK | 915 | MG | U | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126603832 | 12660383 | 1 | Kaposi's sarcoma |
| 126603832 | 12660383 | 2 | Kaposi's sarcoma |
| 126603832 | 12660383 | 3 | Kaposi's sarcoma |
| 126603832 | 12660383 | 4 | Kaposi's sarcoma |
| 126603832 | 12660383 | 5 | Kaposi's sarcoma |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126603832 | 12660383 | HO |
| 126603832 | 12660383 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126603832 | 12660383 | Anaemia | |
| 126603832 | 12660383 | Hyponatraemia |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 126603832 | 12660383 | 1 | 20150305 | 20160728 | 0 | |
| 126603832 | 12660383 | 2 | 20150826 | 20150916 | 0 | |
| 126603832 | 12660383 | 3 | 20150826 | 20151005 | 0 | |
| 126603832 | 12660383 | 4 | 20150305 | 20150618 | 0 | |
| 126603832 | 12660383 | 5 | 20160302 | 20160614 | 0 | |
| 126603832 | 12660383 | 6 | 20160804 | 0 |